最後更新 2024-05-14 07:27:06 (UTC+8)

基本分析

透過季節調整季營收,判斷美股整體趨勢,但注意股價有時候領先基本面的數據,應搭配其他領先指標判斷。

季營收趨勢 tooltip

季節調整季營收
季增率

8.2%


截至2024-03-31

基本資料

個股的基本資料,以及所屬的類股和產業。

公司介紹

業務介紹

波士頓科學公司是一家在全球各種介入醫學專業領域開發、製造和銷售醫療設備的公司。它通過三個部門運營:醫療外科、節律和神經以及心血管。該公司提供用於診斷和治療胃腸和肺部疾病的設備;用於治療各種泌尿和骨盆疾病的設備;可植入的心律轉復合併治療除顫器和可植入的心臟再同步治療除顫器;心臟起搏器和可植入的心臟再同步治療起搏器;以及遠程患者管理系統。它還提供診斷和治療心臟節律異常的醫療技術,包括3D心臟映射和導航解決方案、消融導管、診斷導管、映射導管、心內超聲導管、送達導管和其他配件;用於慢性疼痛管理的脊髓刺激系統;間接減壓系統;以及深部腦刺激系統。此外,該公司還提供介入心臟病學產品,包括用於治療冠狀動脈疾病的藥物洗脫冠狀支架系統;用於治療動脈粥樣硬化的経皮冠狀介入產品;血管內導向超聲成像導管、分數流量儲備裝置和用於冠狀動脈和心臟腔室的系統,以及各種周邊血管;以及結構性心臟治療。此外,它還提供支架、球囊導管、導線和動脈切除系統來治療動脈疾病;血栓切除和聲波脈衝溶栓系統、導線和支架來治療靜脈疾病;以及周邊栓塞裝置、放射性微球、消融系統、冷凍消融系統和微型引流導管來治療癌症。該公司成立於1979年,總部位於馬薩諸塞州馬爾伯勒市。

Boston Scientific Corporation develops, manufactures, and markets medical devices for use in various interventional medical specialties worldwide. It operates through three segments: MedSurg, Rhythm and Neuro, and Cardiovascular. The company offers devices to diagnose and treat gastrointestinal and pulmonary conditions; devices to treat various urological and pelvic conditions; implantable cardioverter and implantable cardiac resynchronization therapy defibrillators; pacemakers and implantable cardiac resynchronization therapy pacemakers; and remote patient management systems. It also provides medical technologies to diagnose and treat rate and rhythm disorders of the heart comprising 3-D cardiac mapping and navigation solutions, ablation catheters, diagnostic catheters, mapping catheters, intracardiac ultrasound catheters, delivery sheaths, and other accessories; spinal cord stimulator systems for the management of chronic pain; indirect decompression systems; and deep brain stimulation systems. In addition, the company offers interventional cardiology products, including drug-eluting coronary stent systems used in the treatment of coronary artery disease; percutaneous coronary interventions products to treat atherosclerosis; intravascular catheter-directed ultrasound imaging catheters, fractional flow reserve devices, and systems for use in coronary arteries and heart chambers, as well as various peripheral vessels; and structural heart therapies. Further, it provides stents, balloon catheters, wires, and atherectomy systems to treat arterial diseases; thrombectomy and acoustic pulse thrombolysis systems, wires, and stents to treat venous diseases; and peripheral embolization devices, radioactive microspheres, ablation systems, cryotherapy ablation systems, and micro and drainage catheters to treat cancer. The company was incorporated in 1979 and is headquartered in Marlborough, Massachusetts.

所屬產業

所屬類股
Healthcare
所屬產業
Medical - Devices

警語

1. 資料僅供參考,不做任何獲利保證及特定股票與點位推薦建議。

2. 資料並不完整,需要完整資料請至相關網站索取。

3. 任何股市數據分析皆存在倖存者偏差。

warning